News

Lupin inches up on collaborating with Mark Cuban Cost Plus Drug Company and COPD Foundation Lupin is currently trading at Rs. 1143.20, up by 4.10 points or 0.36% from its previous closing of Rs. 1139.10 on the BSE. The scrip opened at Rs. 1144.00 and has touched a high and low of Rs. 1148.60 and Rs. 1141.50 respectively. So far 12186 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,148.60 on 7-Sept-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at Rs...
Lupin inches up on collaborating with Mark Cuban Cost Plus Drug Company and COPD Foundation
Lupin inches up on collaborating with Mark Cuban Cost Plus Drug Company and COPD Foundation
Source: Accord Fintech
7/09/2023 10:48:08 AM
Lupin moves up as its arm launches Propranolol LA capsules Lupin is currently trading at Rs. 1106.00, up by 8.95 points or 0.82% from its previous closing of Rs. 1097.05 on the BSE. The scrip opened at Rs. 1118.15 and has touched a high and low of Rs. 1118.15 and Rs. 1103.60 respectively. So far 4648 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1143.70 on 17-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at Rs. ...
Lupin moves up as its arm launches Propranolol LA capsules
Lupin moves up as its arm launches Propranolol LA capsules
Source: Reuters
30/08/2023 9:59:49 AM
Stock Picks : Lupin Ltd And Bharat Heavy Electricals Ltd By ICICI Direct Lupin Ltd Buy Lupin Ltd @1104-1106; Target 1118.00; Stop Loss 1098.40   Bharat Heavy Electricals Ltd Buy Bharat Heavy Electricals Ltd @ 108.90-109.30; Target 110.80; Stop Loss 108.40   To Read Complete Report & Disclaimer Click Here   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631   Above views are of the author and not of ...
Stock Picks : Lupin Ltd And Bharat Heavy Electricals Ltd By ICICI Direct
Stock Picks : Lupin Ltd And Bharat Heavy Electricals Ltd By ICICI Direct
Source: ICICI Direct
29/08/2023 11:03:28 AM
Lupin soars on getting USFDA`s nod for Pirfenidone Tablets Lupin is currently trading at Rs. 1096.70, up by 19.15 points or 1.78% from its previous closing of Rs. 1077.55 on the BSE. The scrip opened at Rs. 1077.55 and has touched a high and low of Rs. 1097.40 and Rs. 1076.05 respectively. So far 20162 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1143.70 on 17-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at Rs...
Lupin soars on getting USFDA`s nod for Pirfenidone Tablets
Lupin soars on getting USFDA`s nod for Pirfenidone Tablets
Source: Accord Fintech
28/08/2023 2:43:57 PM
Lupin shines on launching patient support program `Jeet` dedicated to heart-health Lupin is currently trading at Rs. 1136.30, up by 23.35 points or 2.10% from its previous closing of Rs. 1112.95 on the BSE. The scrip opened at Rs. 1129.95 and has touched a high and low of Rs. 1143.70 and Rs. 1123.95 respectively. So far 20646 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,143.70 on 17-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at R...
Lupin shines on launching patient support program `Jeet` dedicated to heart-health
Lupin shines on launching patient support program `Jeet` dedicated to heart-health
Source: Accord Fintech
17/08/2023 9:48:40 AM
Lupin trades higher on receiving USFDA`s approval for Doxycycline Hyclate Delayed-Release Tablets Lupin is currently trading at Rs. 1091.25, up by 9.55 points or 0.88% from its previous closing of Rs. 1081.70 on the BSE. The scrip opened at Rs. 1094.75 and has touched a high and low of Rs. 1094.75 and Rs. 1078.60 respectively. So far 12461 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1108.95 on 09-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at Rs....
Lupin trades higher on receiving USFDA`s approval for Doxycycline Hyclate Delayed-Release Tablets
Lupin trades higher on receiving USFDA`s approval for Doxycycline Hyclate Delayed-Release Tablets
Source: Accord Fintech
16/08/2023 11:29:20 AM
Lupin rises as its Mandideep Unit-2 Facility completes USFDA inspection with No Observations Lupin is currently trading at Rs. 1089.75, up by 12.80 points or 1.19% from its previous closing of Rs. 1076.95 on the BSE. The scrip opened at Rs. 1077.35 and has touched a high and low of Rs. 1105.80 and Rs. 1077.35 respectively. So far 54151 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1108.95 on 09-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at Rs...
Lupin rises as its Mandideep Unit-2 Facility completes USFDA inspection with No Observations
Lupin rises as its Mandideep Unit-2 Facility completes USFDA inspection with No Observations
Source: Nirmal Bang Ltd
14/08/2023 11:09:52 AM
Lupin shines as its arm gets USFDA`s approval for Fluocinolone Acetonide Body Oil Lupin is currently trading at Rs. 1102.95, up by 19.10 points or 1.76% from its previous closing of Rs. 1083.85 on the BSE. The scrip opened at Rs. 1092.00 and has touched a high and low of Rs. 1108.95 and Rs. 1088.25 respectively. So far 12965 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,108.95 on 09-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at R...
Lupin shines as its arm gets USFDA`s approval for Fluocinolone Acetonide Body Oil
Lupin shines as its arm gets USFDA`s approval for Fluocinolone Acetonide Body Oil
Source: Accord Fintech
9/08/2023 9:41:21 AM
Lupin zooms on reporting consolidated net profit of Rs 452 crore in Q1FY24 Lupin is currently trading at Rs. 1073.45, up by 37.60 points or 3.63% from its previous closing of Rs. 1035.85 on the BSE. The scrip opened at Rs. 1030.40 and has touched a high and low of Rs. 1078.00 and Rs. 1011.10 respectively. So far 215429 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1078.00 on 04-Aug-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at R...
Lupin zooms on reporting consolidated net profit of Rs 452 crore in Q1FY24
Lupin zooms on reporting consolidated net profit of Rs 452 crore in Q1FY24
Source: Accord Fintech
4/08/2023 3:25:33 PM
Lupin shines as its arm gets USFDA`s approval for Fluocinolone Acetonide Topical Oil Lupin is currently trading at Rs. 1035.80, up by 41.90 points or 4.22% from its previous closing of Rs. 993.90 on the BSE. The scrip opened at Rs. 994.95 and has touched a high and low of Rs. 1040.75 and Rs. 989.30 respectively. So far 123039 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1040.75 on 03-Aug-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. ...
Lupin shines as its arm gets USFDA`s approval for Fluocinolone Acetonide Topical Oil
Lupin shines as its arm gets USFDA`s approval for Fluocinolone Acetonide Topical Oil
Source: Accord Fintech
3/08/2023 2:43:43 PM
Lupin rises on getting tentative approval for Dolutegravir Lamivudine & Tenofovir Alafenamide Tablets Lupin is currently trading at Rs. 938.60, up by 3.75 points or 0.40% from its previous closing of Rs. 934.85 on the BSE. The scrip opened at Rs. 943.95 and has touched a high and low of Rs. 945.00 and Rs. 937.80 respectively. So far 7417 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 947.95 on 21-Jul-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 947.95...
Lupin rises on getting tentative approval for Dolutegravir Lamivudine & Tenofovir Alafenamide Tablets
Lupin rises on getting tentative approval for Dolutegravir Lamivudine & Tenofovir Alafenamide Tablets
Source: Accord Fintech
24/07/2023 12:20:10 PM
Lupin gains on receiving EIR from USFDA for Pithampur Unit-2 Manufacturing Facility Lupin is currently trading at Rs. 920.00, up by 7.10 points or 0.78% from its previous closing of Rs. 912.90 on the BSE. The scrip opened at Rs. 928.00 and has touched a high and low of Rs. 934.90 and Rs. 915.60 respectively. So far 11476 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 934.90 on 12-Jul-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 934.9...
Lupin gains on receiving EIR from USFDA for Pithampur Unit-2 Manufacturing Facility
Lupin gains on receiving EIR from USFDA for Pithampur Unit-2 Manufacturing Facility
Source: accourd fintech
12/07/2023 10:08:19 AM
Lupin rises on getting tentative approval from USFDA for Dolutegravir Tablets Lupin is currently trading at Rs. 901.65, up by 10.75 points or 1.21% from its previous closing of Rs. 890.90 on the BSE. The scrip opened at Rs. 894.35 and has touched a high and low of Rs. 902.40 and Rs. 894.35 respectively. So far 2716 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 908.65 on 30-Jun-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 908.6...
Lupin rises on getting tentative approval from USFDA for Dolutegravir Tablets
Lupin rises on getting tentative approval from USFDA for Dolutegravir Tablets
Source: Accord Fintech
5/07/2023 9:54:51 AM
Lupin moves up on getting approval from USFDA for Cyanocobalamin Nasal Spray Lupin is currently trading at Rs. 898.00, up by 5.55 points or 0.62% from its previous closing of Rs. 892.45 on the BSE. The scrip opened at Rs. 885.55 and has touched a high and low of Rs. 902.00 and Rs. 885.55 respectively. So far 10866 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 908.65 on 30-Jun-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 908.6...
Lupin moves up on getting approval from USFDA for Cyanocobalamin Nasal Spray
Lupin moves up on getting approval from USFDA for Cyanocobalamin Nasal Spray
Source: Accord Fintech
4/07/2023 10:49:24 AM
Sell Lupin Ltd For Target Rs. 700- Motilal Oswal Financial Services g-Spiriva approval potential growth driver for North America business * Lupin (LPC) received the much-awaited USFDA approval for g-Spiriva. Since it is a niche product in the inhaler space, it is expected to boost sales in North America. * We estimate annual sales of USD80-100m from this opportunity in FY24/FY25. * We raise our FY24/FY25 earnings estimates by 6%/8% to factor in the upside in earnings from g-Spiriva. We value LPC at 22x 12M forward earnings to arrive at a TP of INR700...
Sell Lupin Ltd For Target Rs. 700- Motilal Oswal Financial Services
Sell Lupin Ltd For Target Rs. 700- Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services
23/06/2023 3:30:15 PM
Lupin surges on launching Rufinamide Oral Suspension in United States Lupin is currently trading at Rs. 856.30, up by 4.40 points or 0.52% from its previous closing of Rs. 851.90 on the BSE. The scrip opened at Rs. 850.05 and has touched a high and low of Rs. 865.55 and Rs. 847.85 respectively. So far 136244 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 885.00 on 21-Jun-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 885....
Lupin surges on launching Rufinamide Oral Suspension in United States
Lupin surges on launching Rufinamide Oral Suspension in United States
Source: Accord Fintech
23/06/2023 2:07:05 PM
Lupin zooms on getting USFDA`s approval for Tiotropium Bromide Inhalation Powder. Lupin is currently trading at Rs. 875.00, up by 45.35 points or 5.47% from its previous closing of Rs. 829.65 on the BSE. The scrip opened at Rs. 834.95 and has touched a high and low of Rs. 885.00 and Rs. 829.25 respectively. So far 174889 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 885.00 on 21-Jun-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 885...
Lupin zooms on getting USFDA`s approval for Tiotropium Bromide Inhalation Powder.
Lupin zooms on getting USFDA`s approval for Tiotropium Bromide Inhalation Powder.
Source: Accord Fintech
21/06/2023 3:33:37 PM
Lupin gains on launching Thiamine Hydrochloride Injection in United States Lupin is currently trading at Rs. 832.50, up by 1.65 points or 0.20% from its previous closing of Rs. 830.85 on the BSE. The scrip opened at Rs. 821.00 and has touched a high and low of Rs. 833.85 and Rs. 821.00 respectively. So far 11156 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 843.40 on 16-Jun-2023 and a 52 week low of Rs. 592.55 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs. 843.4...
Lupin gains on launching Thiamine Hydrochloride Injection in United States
Lupin gains on launching Thiamine Hydrochloride Injection in United States
Source: Accord Fintech
19/06/2023 12:25:32 PM
Stock Picks : Reliance Industries Ltd and Lupin Ltd By ICICI Direct Reliance Industries Ltd  Buy Reliance Industries Ltd @2551-2555 CMP 2552.55; Target 2588.00; Stop Loss 2534.80   Lupin Ltd Buy Lupin Ltd @835-837 CMP 834.75; Target 847.50; Stop Loss 829.80   To Read Complete Report & Disclaimer Click Here   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631 ...
Stock Picks : Reliance Industries Ltd and Lupin Ltd By ICICI Direct
Stock Picks : Reliance Industries Ltd and Lupin Ltd By ICICI Direct
Source: ICICI Direct
16/06/2023 10:05:58 AM
Lupin gains on launching Darunavir Tablets Lupin is currently trading at Rs. 822.10, up by 4.95 points or 0.61% from its previous closing of Rs. 817.15 on the BSE. The scrip opened at Rs. 823.15 and has touched a high and low of Rs. 830.30 and Rs. 818.35 respectively. So far 22411 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 830.30 on 05-Jun-2023 and a 52 week low of Rs. 592.55 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs. 830.3...
Lupin gains on launching Darunavir Tablets
Lupin gains on launching Darunavir Tablets
Source: Accord Fintech
5/06/2023 10:04:06 AM
Lupin rises on getting USFDA`s approval for Obeticholic Acid Tablets Lupin is currently trading at Rs. 812.90, up by 8.35 points or 1.04% from its previous closing of Rs. 804.55 on the BSE. The scrip opened at Rs. 800.05 and has touched a high and low of Rs. 816.90 and Rs. 800.05 respectively. So far 3322 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 816.90 on 1-June-2023 and a 52 week low of Rs. 592.55 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs. 816.90...
Lupin rises on getting USFDA`s approval for Obeticholic Acid Tablets
Lupin rises on getting USFDA`s approval for Obeticholic Acid Tablets
Source: Accord Fintech
1/06/2023 9:53:59 AM
Lupin gains on entering into collaboration with Enzene Biosciences to launch Cetuximab Lupin is currently trading at Rs. 811.50, up by 7.85 points or 0.98% from its previous closing of Rs 803.65 on the BSE. The scrip opened at Rs. 810.00 and has touched a high and low of Rs. 813.00 and Rs. 804.35 respectively. So far 8809 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 813.30 on 30-May-2023 and a 52 week low of Rs. 592.55 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs. 813.30 ...
Lupin gains on entering into collaboration with Enzene Biosciences to launch Cetuximab
Lupin gains on entering into collaboration with Enzene Biosciences to launch Cetuximab
Source: Accord Fintech
31/05/2023 10:15:01 AM
Lupin inches up as its arm gets nod to market generic version of Spiriva Lupin inches up as its arm gets nod to market generic version of Spiriva May-29-2023   09:27 Hrs IST Lupin is currently trading at Rs. 782.95, up by 3.30 points or 0.42% from its previous closing of Rs. 779.65 on the BSE. The scrip opened at Rs. 780.15 and has touched a high and low of Rs. 788.20 and Rs. 780.00 respectively.  The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 799.65 on 15-May-2023 and a 52 week low of Rs. 592.55 on...
Lupin inches up as its arm gets nod to market generic version of Spiriva
Lupin inches up as its arm gets nod to market generic version of Spiriva
Source: Accord Fintech
29/05/2023 9:45:03 AM
India's MedPlus Health posts two-fold surge in Q4 profit on strong sales India's MedPlus Health Services reported a two-fold surge in fourth-quarter profit on Thursday, driven by strong sales in its key retail segment. The omnichannel retail pharmacy said its consolidated net profit rose to 265.8 million rupees ($3.21 million) for the quarter ended March 31, from 117.3 million rupees a year ago. The company's consolidated revenue from operations rose 30%, thriving on the back of improved accessibility among consumers - the company sells medicines onl...
India's MedPlus Health posts two-fold surge in Q4 profit on strong sales
India's MedPlus Health posts two-fold surge in Q4 profit on strong sales
Source: Reuters
26/05/2023 9:00:35 AM
Buy Lupin Ltd For Target Rs. 920 - Yes Securities Result Synopsis Lupin reported a better quarter as margin came ahead of expectation partly aided by PLI grant but mostly owing to a better US margin performance QoQ and growth across other geographies + 46% rise in API business QoQ. Assessing the strength of US business is the key to understand margin trajectory and looking to FY24 reckon there could be known but still important margin levers like 1) Spiriva approval and launch in Sep 2) better US pricing environment (comments of generic c...
Buy Lupin Ltd For Target Rs. 920 - Yes Securities
Buy Lupin Ltd For Target Rs. 920 - Yes Securities
Source: Yes Securities Ltd
21/05/2023 3:21:52 PM
Lupin jumps on inking pact to acquire Medisol Lupin is currently trading at Rs. 721.05, up by 16.40 points or 2.33% from its previous closing of Rs. 704.65 on the BSE. The scrip opened at Rs. 705.25 and has touched a high and low of Rs. 724.60 and Rs. 704.05 respectively. So far 30533 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 788.90 on 23-Dec-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 727....
Lupin jumps on inking pact to acquire Medisol
Lupin jumps on inking pact to acquire Medisol
Source: Accord Fintech
8/05/2023 2:43:28 PM
Lupin announces acquisition of French pharma company Medisol Global pharma major Lupin Limited on Friday announced that it has entered into a definitive agreement to acquire the entire share capital of French pharmaceutical company, Medisol. Founded in 2011, Medisol specialises in Generics Injectable products and is engaged in developing and commercialising its products in France, in pharmacies and in hospitals. With this acquisition, Lupin will gain access to Medisol's portfolio of seven injectable products across four therapeutic areas, inc...
Lupin announces acquisition of French pharma company Medisol
Lupin announces acquisition of French pharma company Medisol
Source: IANS
6/05/2023 9:31:53 AM
Stock Picks : Lupin Ltd and State Bank of India (STABAN) By ICICI Direct Lupin (LUPIN) Buy Lupin (LUPIN) CMP 684.25: Initiation Range 683-685: Target 693.90: Stop Loss 677.30   State Bank of India (STABAN) Buy State Bank of India (STABAN) CMP 544.80: Initiation Range 544.50-545.30: Target 552.90: Stop Loss 539.80   To Read Complete Report & Disclaimer Click Here   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ...
Stock Picks : Lupin Ltd and State Bank of India (STABAN) By ICICI Direct
Stock Picks : Lupin Ltd and State Bank of India (STABAN) By ICICI Direct
Source: ICICI Direct
21/04/2023 10:17:32 AM
Lupin zooms on launching Regional Reference Laboratory in Bengaluru Lupin is currently trading at Rs. 678.80, up by 18.45 points or 2.79% from its previous closing of Rs. 660.35 on the BSE. The scrip opened at Rs. 666.40 and has touched a high and low of Rs. 680.75 and Rs. 660.30 respectively. So far 51172 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 797.00 on 20-Apr-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 680....
Lupin zooms on launching Regional Reference Laboratory in Bengaluru
Lupin zooms on launching Regional Reference Laboratory in Bengaluru
Source: Accord Fintech
12/04/2023 1:39:21 PM
Key Stock Ideas: AMG Media Networks, HDFC, Lupin ,Aditya Birla Capital - ARETE Securities Adani's AMG Media acquires 49% in Quintillion Business Media for Rs 48 cr: AMG Media Networks has acquired about a 49 per cent stake in Raghav Bahl-curated digital business news platform Quintillion Business Media Pvt Ltd for about Rs 48 crore. In a stock exchange filing, Adani Enterprises Ltd said its subsidiary AMG Media Networks Ltd has completed the acquisition which was originally announced in May last year. The transaction was completed on March 27 for "Rs 47.84 crore", it...
Key Stock Ideas: AMG Media Networks, HDFC, Lupin ,Aditya Birla Capital - ARETE Securities
Key Stock Ideas: AMG Media Networks, HDFC, Lupin ,Aditya Birla Capital - ARETE Securities
Source: ARETE Securities Ltd
28/03/2023 10:04:29 AM
Lupin zooms on getting USFDA`s tentative approval for Valbenazine Capsules Lupin zooms on getting USFDA’s tentative approval for Valbenazine Capsules Mar-27-2023   11:05 Hrs IST Lupin is currently trading at Rs. 668.70, up by 28.95 points or 4.53% from its previous closing of Rs. 639.75 on the BSE. The scrip opened at Rs. 645.00 and has touched a high and low of Rs. 669.00 and Rs. 642.25 respectively. So far 33583 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.9...
Lupin zooms on getting USFDA`s tentative approval for Valbenazine Capsules
Lupin zooms on getting USFDA`s tentative approval for Valbenazine Capsules
Source: Accord Fintech
27/03/2023 11:45:38 AM
Lupin moves up on getting USFDA`s tentative approval for Obeticholic Acid Tablets Lupin is currently trading at Rs. 652.00, up by 3.50 points or 0.54% from its previous closing of Rs. 648.50 on the BSE. The scrip opened at Rs. 654.95 and has touched a high and low of Rs. 654.95 and Rs. 646.75 respectively. So far 6037 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.90 on 05-Apr-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 665.65...
Lupin moves up on getting USFDA`s tentative approval for Obeticholic Acid Tablets
Lupin moves up on getting USFDA`s tentative approval for Obeticholic Acid Tablets
Source: Accord Fintech
24/03/2023 10:55:39 AM
Lupin jumps on receiving USFDA`s approval for Brexpiprazole Tablets Lupin is currently trading at Rs. 656.75, up by 7.75 points or 1.19% from its previous closing of Rs. 649.00 on the BSE. The scrip opened at Rs. 650.00 and has touched a high and low of Rs. 658.80 and Rs. 649.05 respectively. So far 7530 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.90 on 05-Apr-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 668.75...
Lupin jumps on receiving USFDA`s approval for Brexpiprazole Tablets
Lupin jumps on receiving USFDA`s approval for Brexpiprazole Tablets
Source: Accord Fintech
22/03/2023 4:40:25 PM
Tech Stars : Buy Indian Oil Corporation Ltd For Target Rs.87 - Religare Broking Indian Oil Corporation Limited TECHNICAL RATIONALE– IOC has been trading in a broader range of 65-85 levels for last one year, after the failed attempt to surpass the hurdle of previous swing high. It has formed a fresh base around the support zone of multiple moving averages and looks set to surpass the upper band of the range soon. Buy Indian Oil Corporation Limited CMP 80.40; Initiation Range 80-81; Stop Loss 77.5; Target 87   Lupin Limited TECHNICAL RATIONALE...
Tech Stars : Buy Indian Oil Corporation Ltd For Target Rs.87 - Religare Broking
Tech Stars : Buy Indian Oil Corporation Ltd For Target Rs.87 - Religare Broking
Source: Religare Broking Ltd
21/03/2023 11:00:55 AM
Lupin inches up as its alliance partner gets USFDA`s final approval for Rocuronium Bromide Injection Lupin is currently trading at Rs. 648.10, up by 1.90 points or 0.29% from its previous closing of Rs. 646.20 on the BSE. The scrip opened at Rs. 657.00 and has touched a high and low of Rs. 657.00 and Rs. 646.80 respectively. So far 1627 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.90 on 05-Apr-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 668.80...
Lupin inches up as its alliance partner gets USFDA`s final approval for Rocuronium Bromide Injection
Lupin inches up as its alliance partner gets USFDA`s final approval for Rocuronium Bromide Injection
Source: ACCCORD FINTECH
21/03/2023 9:47:22 AM
Lupin soars on launching Lurasidone Hydrochloride Tablets in United States Lupin is currently trading at Rs. 668.80, up by 1.95 points or 0.29% from its previous closing of Rs. 666.85 on the BSE. The scrip opened at Rs. 666.50 and has touched a high and low of Rs. 673.25 and Rs. 663.30 respectively. So far 11789 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.90 on 05-Apr-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 686.8...
Lupin soars on launching Lurasidone Hydrochloride Tablets in United States
Lupin soars on launching Lurasidone Hydrochloride Tablets in United States
Source: Accord Fintech
21/02/2023 3:03:39 PM
Add Lupin Ltd For Target Rs. 900 - Yes Securities Too much reliance on Spiriva a key risk Result Synopsis Lupin clocked early double digit margin in a quarter which had seasonal US tailwinds and least of price erosion impact in last 4 quarters. Management has pinned hopes on Spiriva approval in April/July which would take margin beyond 15-16% next fiscal. But we reckon more than Spiriva, it is the underlying margin damage (ex NCE R&D) that occurred in US business which is hampering the margin turnaround. Indeed, if we look at other...
Add Lupin Ltd For Target Rs. 900 - Yes Securities
Add Lupin Ltd For Target Rs. 900 - Yes Securities
Source: Yes Securities Ltd
15/02/2023 11:24:07 AM
Downgrade to SELL Lupin Ltd For Target Rs.610 - Motilal Oswal Financial Services Opex remains high; wait continues for g-Spiriva approval Valuation expensive; downgrade to SELL * LPC reported a slightly better-than-expected operational performance in 3QFY23, driven by a better off-take of seasonal products and a robust momentum in the ROW/API segments. However, due to higher interest/tax expenses, earnings declined on the YoY basis. * We cut our EPS estimates for FY23/FY24/FY25 by 41%/6%/5%, factoring in 1) a delay in g-Spiriva approval, 2) increased operational ...
Downgrade to SELL Lupin Ltd For Target Rs.610 - Motilal Oswal Financial Services
Downgrade to SELL Lupin Ltd For Target Rs.610 - Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services Ltd
13/02/2023 3:02:55 PM
Lupin trades higher on receiving USFDA`s approval for Glycopyrrolate Injection Lupin is currently trading at Rs. 781.45, up by 6.20 points or 0.80% from its previous closing of Rs. 775.25 on the BSE. The scrip opened at Rs. 775.35 and has touched a high and low of Rs. 781.75 and Rs. 765.75 respectively. So far 22462 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 812.30 on 10-Feb-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 785.6...
Lupin trades higher on receiving USFDA`s approval for Glycopyrrolate Injection
Lupin trades higher on receiving USFDA`s approval for Glycopyrrolate Injection
Source: Accord Fintech
9/02/2023 11:37:19 AM
Lupin jumps on getting USFDA`s tentative approval for DETAF Tablets Lupin is currently trading at Rs. 740.30, up by 5.90 points or 0.80% from its previous closing of Rs. 734.40 on the BSE. The scrip opened at Rs. 730.05 and has touched a high and low of Rs. 740.30 and Rs. 727.55 respectively. So far 5832 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 922.50 on 01-Feb-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 752.90...
Lupin jumps on getting USFDA`s tentative approval for DETAF Tablets
Lupin jumps on getting USFDA`s tentative approval for DETAF Tablets
Source: Accord Fintech
31/01/2023 2:31:12 PM
Stock of the day : Buy Lupin Ltd For Target Rs.795 - Religare Broking Stock of the day * We are seeing mixed trend in the pharma space and LUPIN looks set to resume the recovery phase. * It has formed a fresh buying pivot while holding firmly above the support zone of short term moving average i.e. 20 EMA on the daily chart. * It might face marginal hurdle at 785 and then we expect to inch gradually towards 830 levels. * We thus recommend creating fresh longs in the mentioned zone. Buy LUPIN Ltd CMP: 767.15 Range: 760-765  SL: 749&...
Stock of the day : Buy Lupin Ltd For Target Rs.795 - Religare Broking
Stock of the day : Buy Lupin Ltd For Target Rs.795 - Religare Broking
Source: Religare Broking Ltd
19/01/2023 9:58:47 AM
Lupin moves up on getting reimbursement approval of NaMuscla in Spain Lupin is currently trading at Rs. 759.60, up by 10.40 points or 1.39% from its previous closing of Rs. 749.20 on the BSE. The scrip opened at Rs. 755.80 and has touched a high and low of Rs. 762.00 and Rs. 750.00 respectively. So far 8737 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 971.30 on 13-Jan-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 762.0...
Lupin moves up on getting reimbursement approval of NaMuscla in Spain
Lupin moves up on getting reimbursement approval of NaMuscla in Spain
Source: Accord Fintech
10/01/2023 10:31:01 AM
Lupin rises on launching novel fixed-dose triple drug for managing inadequately controlled asthma amongst patients Lupin is currently trading at Rs. 738.00, up by 4.95 points or 0.68% from its previous closing of Rs. 733.05 on the BSE. The scrip opened at Rs. 730.00 and has touched a high and low of Rs. 739.70 and Rs. 730.00 respectively. So far 3014 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 971.30 on 13-Jan-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 744.20...
Lupin rises on launching novel fixed-dose triple drug for managing inadequately controlled asthma amongst patients
Lupin rises on launching novel fixed-dose triple drug for managing inadequately controlled asthma amongst patients
Source: Accord Fintech
5/01/2023 11:45:42 AM
Lupin trades higher on the bourses Lupin is currently trading at Rs. 779.40, up by 11.05 points or 1.44% from its previous closing of Rs. 768.35 on the BSE. The scrip opened at Rs. 766.45 and has touched a high and low of Rs. 788.90 and Rs. 760.70 respectively. So far 59792 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 971.30 on 13-Jan-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 788....
Lupin trades higher on the bourses
Lupin trades higher on the bourses
Source: Accord Fintech
23/12/2022 10:39:51 AM
Lupin moves up on launching Regional Reference Laboratory in Indore Lupin is currently trading at Rs. 756.35, up by 5.10 points or 0.68 % from its previous closing of Rs. 751.25 on the BSE. The scrip opened at Rs. 755.00 and has touched a high and low of Rs. 764.70 and Rs. 749.60 respectively. So far 16828 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 971.30 on 13-Jan-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 762....
Lupin moves up on launching Regional Reference Laboratory in Indore
Lupin moves up on launching Regional Reference Laboratory in Indore
Source: Accord Fintech
22/12/2022 10:58:40 AM
Lupin surges on receiving USFDA`s approval for Brivaracetam Tablets Lupin is currently trading at Rs. 750.75, up by 25.55 points or 3.52% from its previous closing of Rs. 725.20 on the BSE. The scrip opened at Rs. 725.55 and has touched a high and low of Rs. 757.25 and Rs. 722.60 respectively. So far 29534 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 971.30 on 13-Jan-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 762....
Lupin surges on receiving USFDA`s approval for Brivaracetam Tablets
Lupin surges on receiving USFDA`s approval for Brivaracetam Tablets
Source: Accord Fintech
21/12/2022 2:24:28 PM
Reduce Lupin Ltd For Target Rs.626 - ICICI Securities US recovers; launches remain key Lupin’s Q2FY23 performance was above our estimates with better than expected US sales. Revenue grew 1.3% YoY and 10.7% QoQ to Rs41.5bn (I-Sec: Rs39.7bn). US revenue was up 31.4% QoQ at US$159mn (I-Sec:US$150mn) led by recovery in the base business and launch of Suprep. EBITDA margin witnessed a healthy expansion of 470bps QoQ to 10.9% (I-Sec: 9.0%) led by higher gross margin and operating leverage. Near-term growth momentum is highly dependent on trac...
Reduce Lupin Ltd For Target Rs.626 - ICICI Securities
Reduce Lupin Ltd For Target Rs.626 - ICICI Securities
Source: ICICI Securities Ltd
10/12/2022 10:25:18 AM
Add Lupin Ltd For Target Rs.750 - Yes Securities US approvals key to sustained momentum Result Synopsis Lupin reported an in line quarter with recovery in US aided by growth across emerging markets. A 30% QoQ jump in US led to improved gross (also helped by price hikes in India YoY) and EBIDTA margin despite India business staying flat YoY as diabetes and cardiac in-licensed products experienced erosion. While company had alluded to cost cutting in previous quarter, higher other line expenses precluded any headline cost savings. Lu...
Add Lupin Ltd For Target Rs.750 - Yes Securities
Add Lupin Ltd For Target Rs.750 - Yes Securities
Source: Yes Securities Ltd
6/12/2022 10:27:06 AM